Date | Title | Sponsor |
| 2006-present | A Clinical trial of Ceftriaxone in Subjects with Amyotrophic Lateral Sclerosis | National Institutes of Health |
| 2007-present | Electrical Impedance Myography in ALS | ALS Association |
| 2008-present | ALS Biomarker Study | ALS Association |
| 2009-present | A Clinical Trial of Lithium and Riluzole in ALS | National Institutes of Health |
| 2008-present | CSF Indicators for Diagnosis and Disease Progression in ALS | National Institutes of Health |
| 2009-present | Early Events at the Neuromuscular Junction in ALS | WFUHS Translational Science Institute |
| 2003-2007 | A Multi-Center Study of Minocycline in ALS | National Institutes of Health |
| 2006-2009 | Ultrasound of peripheral nerves in ALS | Muscular Dystrophy Association |
| 2006-2007 | ALSRG Collection of Data and Biomaterial for Repository Banking to Facilitate Research into the Etiology of ALS and Related Motor Neuron Diseases | National Institutes of Health |
| 1997-2000 | Efficacy, Safety, Tolerability Study of SR57746A in Patients with Amyotrophic Lateral Sclerosis | Sanofi Recherche |
| 2000-2002 | A Clinical Trial of Topiramate in ALS | Ortho-McNeil Pharmaceuticals |
| 2001-2003 | Motor Neuron Trophic/Toxic Substances in Cerebrospinal Fluid and Serum in ALS Patients | WFSM Intramural Research |
| 2001-2003 | A Double-Blind, Controlled, Multicenter Phase 2/3 Study to Assess the Safety and Efficacy of AVP-923 in the Treatment of Pseudobulbar Affect in Patients with Amyotrophic Lateral Sclerosis | Avanir Pharmaceuticals (99-AVR-102) |
| 2000-2003 | A Clinical Trial of Creatine in ALS | Muscular Dystrophy Association |
| 2003-2004 | ALS and Hsp70: A Potential New Therapy | WFSM Center for Investigative Neuroscience |
| 2003-2004 | A Clinical Trial of Coenzyme Q10 in Patients with Amyotrophic Lateral Sclerosis (ALS) | Muscular Dystrophy Association/Pharmacia |
| 2001-2005 | A Clinical Trial of Celebrex in Subjects with Amyotrophic Lateral Sclerosis | Muscular Dystrophy Association/Pharmacia/Pfizer |